Home » Topics » BioWorld Science

BioWorld Science
RSS

AT: all bad for platelets

July 23, 2018

First biomarker for liver injury from biologic

July 23, 2018

The Yang to KRAS' Yin?

July 23, 2018

Sending live phages after deadly lung infections

July 23, 2018

Membrane findings point to new antimalarial strategies

July 23, 2018

Gritstone Oncology to test GRANITE-001 with Opdivo and Yervoy

July 23, 2018

Phase IIa study of BT-063 for the treatment of SLE meets primary endpoint

July 23, 2018

Transgenic mouse model useful to study the hypersensitivity reactions of abacavir

July 23, 2018

Positive data presented from SEQUOIA and CEDAR phase III studies of abicipar

July 23, 2018

Epizyme discovers EHMT1 and/or EHMT2 inhibitors

July 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...